nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP3A4—Thiotepa—urinary bladder cancer	0.048	0.287	CbGbCtD
Aminophylline—CYP2E1—Etoposide—urinary bladder cancer	0.043	0.257	CbGbCtD
Aminophylline—PDE3A—penis—urinary bladder cancer	0.0332	0.166	CbGeAlD
Aminophylline—CYP1A2—Fluorouracil—urinary bladder cancer	0.0298	0.178	CbGbCtD
Aminophylline—CYP1A2—Etoposide—urinary bladder cancer	0.0249	0.148	CbGbCtD
Aminophylline—CYP3A4—Etoposide—urinary bladder cancer	0.013	0.0777	CbGbCtD
Aminophylline—ADORA2B—prostate gland—urinary bladder cancer	0.0108	0.0537	CbGeAlD
Aminophylline—CYP1A2—urine—urinary bladder cancer	0.00979	0.0489	CbGeAlD
Aminophylline—PDE4A—prostate gland—urinary bladder cancer	0.0096	0.0479	CbGeAlD
Aminophylline—CYP3A4—Doxorubicin—urinary bladder cancer	0.00888	0.053	CbGbCtD
Aminophylline—CYP2E1—urine—urinary bladder cancer	0.00881	0.0439	CbGeAlD
Aminophylline—PDE3A—prostate gland—urinary bladder cancer	0.00794	0.0396	CbGeAlD
Aminophylline—HDAC2—prostate gland—urinary bladder cancer	0.00764	0.0381	CbGeAlD
Aminophylline—ADORA2B—smooth muscle tissue—urinary bladder cancer	0.00762	0.038	CbGeAlD
Aminophylline—HDAC2—Teniposide—Etoposide—urinary bladder cancer	0.0074	1	CbGdCrCtD
Aminophylline—ADORA2B—urethra—urinary bladder cancer	0.00721	0.036	CbGeAlD
Aminophylline—CYP3A4—urine—urinary bladder cancer	0.00709	0.0354	CbGeAlD
Aminophylline—PDE3A—smooth muscle tissue—urinary bladder cancer	0.00562	0.028	CbGeAlD
Aminophylline—HDAC2—epithelium—urinary bladder cancer	0.00561	0.028	CbGeAlD
Aminophylline—HDAC2—smooth muscle tissue—urinary bladder cancer	0.00541	0.027	CbGeAlD
Aminophylline—ADORA2B—vagina—urinary bladder cancer	0.00532	0.0265	CbGeAlD
Aminophylline—ADORA1—renal system—urinary bladder cancer	0.00527	0.0263	CbGeAlD
Aminophylline—HDAC2—renal system—urinary bladder cancer	0.00521	0.026	CbGeAlD
Aminophylline—ADORA1—urethra—urinary bladder cancer	0.00518	0.0258	CbGeAlD
Aminophylline—ADORA2A—female reproductive system—urinary bladder cancer	0.00489	0.0244	CbGeAlD
Aminophylline—PDE3A—female reproductive system—urinary bladder cancer	0.00433	0.0216	CbGeAlD
Aminophylline—ADORA1—female reproductive system—urinary bladder cancer	0.00422	0.0211	CbGeAlD
Aminophylline—HDAC2—female reproductive system—urinary bladder cancer	0.00417	0.0208	CbGeAlD
Aminophylline—ADORA1—vagina—urinary bladder cancer	0.00382	0.0191	CbGeAlD
Aminophylline—HDAC2—vagina—urinary bladder cancer	0.00377	0.0188	CbGeAlD
Aminophylline—CYP2E1—prostate gland—urinary bladder cancer	0.00316	0.0158	CbGeAlD
Aminophylline—PDE4A—lymph node—urinary bladder cancer	0.00306	0.0153	CbGeAlD
Aminophylline—CYP2E1—seminal vesicle—urinary bladder cancer	0.00267	0.0133	CbGeAlD
Aminophylline—PDE3A—lymph node—urinary bladder cancer	0.00253	0.0126	CbGeAlD
Aminophylline—ADORA1—lymph node—urinary bladder cancer	0.00247	0.0123	CbGeAlD
Aminophylline—HDAC2—lymph node—urinary bladder cancer	0.00244	0.0122	CbGeAlD
Aminophylline—CYP1A2—renal system—urinary bladder cancer	0.0024	0.012	CbGeAlD
Aminophylline—CYP2E1—renal system—urinary bladder cancer	0.00215	0.0108	CbGeAlD
Aminophylline—CYP2E1—urethra—urinary bladder cancer	0.00212	0.0106	CbGeAlD
Aminophylline—CYP3A4—renal system—urinary bladder cancer	0.00173	0.00865	CbGeAlD
Aminophylline—CYP2E1—female reproductive system—urinary bladder cancer	0.00173	0.00861	CbGeAlD
Aminophylline—CYP3A4—female reproductive system—urinary bladder cancer	0.00139	0.00693	CbGeAlD
Aminophylline—Albuminuria—Epirubicin—urinary bladder cancer	0.00129	0.00355	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00129	0.00355	CcSEcCtD
Aminophylline—Hypercalcaemia—Doxorubicin—urinary bladder cancer	0.00129	0.00353	CcSEcCtD
Aminophylline—Haematemesis—Doxorubicin—urinary bladder cancer	0.00129	0.00353	CcSEcCtD
Aminophylline—Haematuria—Thiotepa—urinary bladder cancer	0.00128	0.00351	CcSEcCtD
Aminophylline—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00124	0.00341	CcSEcCtD
Aminophylline—Ventricular arrhythmia—Doxorubicin—urinary bladder cancer	0.00121	0.00331	CcSEcCtD
Aminophylline—Albuminuria—Doxorubicin—urinary bladder cancer	0.0012	0.00329	CcSEcCtD
Aminophylline—Extravasation—Methotrexate—urinary bladder cancer	0.00118	0.00325	CcSEcCtD
Aminophylline—Diarrhoea—Mitomycin—urinary bladder cancer	0.00116	0.0032	CcSEcCtD
Aminophylline—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00114	0.00313	CcSEcCtD
Aminophylline—Dizziness—Mitomycin—urinary bladder cancer	0.00113	0.00309	CcSEcCtD
Aminophylline—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.00111	0.00305	CcSEcCtD
Aminophylline—Extravasation—Epirubicin—urinary bladder cancer	0.00111	0.00304	CcSEcCtD
Aminophylline—Vomiting—Mitomycin—urinary bladder cancer	0.00108	0.00297	CcSEcCtD
Aminophylline—Haematuria—Gemcitabine—urinary bladder cancer	0.00108	0.00295	CcSEcCtD
Aminophylline—Arrhythmia—Thiotepa—urinary bladder cancer	0.00108	0.00295	CcSEcCtD
Aminophylline—Rash—Mitomycin—urinary bladder cancer	0.00107	0.00294	CcSEcCtD
Aminophylline—Dermatitis—Mitomycin—urinary bladder cancer	0.00107	0.00294	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Epirubicin—urinary bladder cancer	0.00107	0.00293	CcSEcCtD
Aminophylline—Headache—Mitomycin—urinary bladder cancer	0.00107	0.00293	CcSEcCtD
Aminophylline—Alopecia—Thiotepa—urinary bladder cancer	0.00106	0.00292	CcSEcCtD
Aminophylline—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.00105	0.00288	CcSEcCtD
Aminophylline—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.00104	0.00286	CcSEcCtD
Aminophylline—Tension—Thiotepa—urinary bladder cancer	0.00103	0.00282	CcSEcCtD
Aminophylline—Extravasation—Doxorubicin—urinary bladder cancer	0.00102	0.00281	CcSEcCtD
Aminophylline—Nervousness—Thiotepa—urinary bladder cancer	0.00102	0.00279	CcSEcCtD
Aminophylline—Nausea—Mitomycin—urinary bladder cancer	0.00101	0.00277	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Doxorubicin—urinary bladder cancer	0.000989	0.00272	CcSEcCtD
Aminophylline—Skin exfoliation—Methotrexate—urinary bladder cancer	0.000985	0.0027	CcSEcCtD
Aminophylline—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.000983	0.0027	CcSEcCtD
Aminophylline—Agitation—Thiotepa—urinary bladder cancer	0.000963	0.00264	CcSEcCtD
Aminophylline—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.000963	0.00264	CcSEcCtD
Aminophylline—Dermatitis contact—Epirubicin—urinary bladder cancer	0.000954	0.00262	CcSEcCtD
Aminophylline—Coma—Methotrexate—urinary bladder cancer	0.000943	0.00259	CcSEcCtD
Aminophylline—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000922	0.00253	CcSEcCtD
Aminophylline—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.00091	0.0025	CcSEcCtD
Aminophylline—Convulsion—Thiotepa—urinary bladder cancer	0.000908	0.00249	CcSEcCtD
Aminophylline—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000905	0.00248	CcSEcCtD
Aminophylline—Alopecia—Gemcitabine—urinary bladder cancer	0.000895	0.00246	CcSEcCtD
Aminophylline—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00089	0.00244	CcSEcCtD
Aminophylline—Anxiety—Thiotepa—urinary bladder cancer	0.000889	0.00244	CcSEcCtD
Aminophylline—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.000883	0.00242	CcSEcCtD
Aminophylline—Coma—Epirubicin—urinary bladder cancer	0.000882	0.00242	CcSEcCtD
Aminophylline—Alopecia—Fluorouracil—urinary bladder cancer	0.00088	0.00242	CcSEcCtD
Aminophylline—Flushing—Cisplatin—urinary bladder cancer	0.000876	0.00241	CcSEcCtD
Aminophylline—Polyuria—Methotrexate—urinary bladder cancer	0.000853	0.00234	CcSEcCtD
Aminophylline—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.000853	0.00234	CcSEcCtD
Aminophylline—Infection—Thiotepa—urinary bladder cancer	0.00085	0.00233	CcSEcCtD
Aminophylline—Arrhythmia—Cisplatin—urinary bladder cancer	0.000844	0.00232	CcSEcCtD
Aminophylline—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000839	0.0023	CcSEcCtD
Aminophylline—Tachycardia—Thiotepa—urinary bladder cancer	0.000835	0.00229	CcSEcCtD
Aminophylline—Alopecia—Cisplatin—urinary bladder cancer	0.000834	0.00229	CcSEcCtD
Aminophylline—Coma—Doxorubicin—urinary bladder cancer	0.000816	0.00224	CcSEcCtD
Aminophylline—Anorexia—Thiotepa—urinary bladder cancer	0.000816	0.00224	CcSEcCtD
Aminophylline—Phlebitis—Epirubicin—urinary bladder cancer	0.000814	0.00223	CcSEcCtD
Aminophylline—Flushing—Etoposide—urinary bladder cancer	0.000803	0.0022	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000794	0.00218	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000774	0.00212	CcSEcCtD
Aminophylline—Tremor—Cisplatin—urinary bladder cancer	0.00077	0.00211	CcSEcCtD
Aminophylline—Alopecia—Etoposide—urinary bladder cancer	0.000764	0.0021	CcSEcCtD
Aminophylline—Dyspepsia—Thiotepa—urinary bladder cancer	0.000753	0.00207	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—urinary bladder cancer	0.000753	0.00207	CcSEcCtD
Aminophylline—Convulsion—Fluorouracil—urinary bladder cancer	0.000751	0.00206	CcSEcCtD
Aminophylline—Decreased appetite—Thiotepa—urinary bladder cancer	0.000744	0.00204	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000743	0.00204	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000724	0.00199	CcSEcCtD
Aminophylline—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00072	0.00198	CcSEcCtD
Aminophylline—Infection—Gemcitabine—urinary bladder cancer	0.000715	0.00196	CcSEcCtD
Aminophylline—Irritability—Methotrexate—urinary bladder cancer	0.000715	0.00196	CcSEcCtD
Aminophylline—Convulsion—Cisplatin—urinary bladder cancer	0.000712	0.00195	CcSEcCtD
Aminophylline—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000708	0.00194	CcSEcCtD
Aminophylline—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000706	0.00194	CcSEcCtD
Aminophylline—Infection—Fluorouracil—urinary bladder cancer	0.000703	0.00193	CcSEcCtD
Aminophylline—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.0007	0.00192	CcSEcCtD
Aminophylline—Anxiety—Cisplatin—urinary bladder cancer	0.000697	0.00191	CcSEcCtD
Aminophylline—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000694	0.0019	CcSEcCtD
Aminophylline—Tachycardia—Fluorouracil—urinary bladder cancer	0.000691	0.0019	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000687	0.00189	CcSEcCtD
Aminophylline—Anorexia—Gemcitabine—urinary bladder cancer	0.000686	0.00188	CcSEcCtD
Aminophylline—Urticaria—Thiotepa—urinary bladder cancer	0.00068	0.00187	CcSEcCtD
Aminophylline—Abdominal pain—Thiotepa—urinary bladder cancer	0.000676	0.00186	CcSEcCtD
Aminophylline—Body temperature increased—Thiotepa—urinary bladder cancer	0.000676	0.00186	CcSEcCtD
Aminophylline—Anorexia—Fluorouracil—urinary bladder cancer	0.000675	0.00185	CcSEcCtD
Aminophylline—Hypotension—Gemcitabine—urinary bladder cancer	0.000673	0.00185	CcSEcCtD
Aminophylline—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000671	0.00184	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00067	0.00184	CcSEcCtD
Aminophylline—Infection—Cisplatin—urinary bladder cancer	0.000666	0.00183	CcSEcCtD
Aminophylline—Hypotension—Fluorouracil—urinary bladder cancer	0.000661	0.00182	CcSEcCtD
Aminophylline—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000658	0.00181	CcSEcCtD
Aminophylline—Tachycardia—Cisplatin—urinary bladder cancer	0.000655	0.0018	CcSEcCtD
Aminophylline—Convulsion—Etoposide—urinary bladder cancer	0.000652	0.00179	CcSEcCtD
Aminophylline—Insomnia—Gemcitabine—urinary bladder cancer	0.000651	0.00179	CcSEcCtD
Aminophylline—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00064	0.00176	CcSEcCtD
Aminophylline—Insomnia—Fluorouracil—urinary bladder cancer	0.00064	0.00176	CcSEcCtD
Aminophylline—Anorexia—Cisplatin—urinary bladder cancer	0.000639	0.00176	CcSEcCtD
Aminophylline—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000638	0.00175	CcSEcCtD
Aminophylline—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00063	0.00173	CcSEcCtD
Aminophylline—Hypotension—Cisplatin—urinary bladder cancer	0.000627	0.00172	CcSEcCtD
Aminophylline—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000626	0.00172	CcSEcCtD
Aminophylline—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000623	0.00171	CcSEcCtD
Aminophylline—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000615	0.00169	CcSEcCtD
Aminophylline—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000615	0.00169	CcSEcCtD
Aminophylline—Infection—Etoposide—urinary bladder cancer	0.000611	0.00168	CcSEcCtD
Aminophylline—Pruritus—Thiotepa—urinary bladder cancer	0.000605	0.00166	CcSEcCtD
Aminophylline—Tachycardia—Etoposide—urinary bladder cancer	0.0006	0.00165	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000592	0.00163	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00059	0.00162	CcSEcCtD
Aminophylline—Anorexia—Etoposide—urinary bladder cancer	0.000586	0.00161	CcSEcCtD
Aminophylline—Diarrhoea—Thiotepa—urinary bladder cancer	0.000585	0.00161	CcSEcCtD
Aminophylline—Decreased appetite—Cisplatin—urinary bladder cancer	0.000583	0.0016	CcSEcCtD
Aminophylline—Hypotension—Etoposide—urinary bladder cancer	0.000574	0.00158	CcSEcCtD
Aminophylline—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000569	0.00156	CcSEcCtD
Aminophylline—Dizziness—Thiotepa—urinary bladder cancer	0.000566	0.00155	CcSEcCtD
Aminophylline—Urticaria—Fluorouracil—urinary bladder cancer	0.000562	0.00154	CcSEcCtD
Aminophylline—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000559	0.00154	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—urinary bladder cancer	0.00055	0.00151	CcSEcCtD
Aminophylline—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000546	0.0015	CcSEcCtD
Aminophylline—Vomiting—Thiotepa—urinary bladder cancer	0.000544	0.00149	CcSEcCtD
Aminophylline—Rash—Thiotepa—urinary bladder cancer	0.000539	0.00148	CcSEcCtD
Aminophylline—Dermatitis—Thiotepa—urinary bladder cancer	0.000539	0.00148	CcSEcCtD
Aminophylline—Headache—Thiotepa—urinary bladder cancer	0.000536	0.00147	CcSEcCtD
Aminophylline—Decreased appetite—Etoposide—urinary bladder cancer	0.000534	0.00147	CcSEcCtD
Aminophylline—Body temperature increased—Cisplatin—urinary bladder cancer	0.00053	0.00146	CcSEcCtD
Aminophylline—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000521	0.00143	CcSEcCtD
Aminophylline—Haematuria—Epirubicin—urinary bladder cancer	0.000515	0.00141	CcSEcCtD
Aminophylline—Pruritus—Gemcitabine—urinary bladder cancer	0.000509	0.0014	CcSEcCtD
Aminophylline—Nausea—Thiotepa—urinary bladder cancer	0.000508	0.0014	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000506	0.00139	CcSEcCtD
Aminophylline—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000503	0.00138	CcSEcCtD
Aminophylline—Pruritus—Fluorouracil—urinary bladder cancer	0.000501	0.00137	CcSEcCtD
Aminophylline—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000494	0.00136	CcSEcCtD
Aminophylline—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000492	0.00135	CcSEcCtD
Aminophylline—Urticaria—Etoposide—urinary bladder cancer	0.000488	0.00134	CcSEcCtD
Aminophylline—Abdominal pain—Etoposide—urinary bladder cancer	0.000486	0.00133	CcSEcCtD
Aminophylline—Body temperature increased—Etoposide—urinary bladder cancer	0.000486	0.00133	CcSEcCtD
Aminophylline—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000484	0.00133	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—urinary bladder cancer	0.000477	0.00131	CcSEcCtD
Aminophylline—Dizziness—Fluorouracil—urinary bladder cancer	0.000468	0.00128	CcSEcCtD
Aminophylline—Diarrhoea—Cisplatin—urinary bladder cancer	0.000459	0.00126	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—urinary bladder cancer	0.000458	0.00126	CcSEcCtD
Aminophylline—Vomiting—Gemcitabine—urinary bladder cancer	0.000458	0.00126	CcSEcCtD
Aminophylline—Rash—Gemcitabine—urinary bladder cancer	0.000454	0.00125	CcSEcCtD
Aminophylline—Dermatitis—Gemcitabine—urinary bladder cancer	0.000453	0.00124	CcSEcCtD
Aminophylline—Hypersensitivity—Etoposide—urinary bladder cancer	0.000453	0.00124	CcSEcCtD
Aminophylline—Headache—Gemcitabine—urinary bladder cancer	0.000451	0.00124	CcSEcCtD
Aminophylline—Flushing—Epirubicin—urinary bladder cancer	0.00045	0.00124	CcSEcCtD
Aminophylline—Vomiting—Fluorouracil—urinary bladder cancer	0.00045	0.00124	CcSEcCtD
Aminophylline—Rash—Fluorouracil—urinary bladder cancer	0.000446	0.00122	CcSEcCtD
Aminophylline—Dermatitis—Fluorouracil—urinary bladder cancer	0.000446	0.00122	CcSEcCtD
Aminophylline—Headache—Fluorouracil—urinary bladder cancer	0.000443	0.00122	CcSEcCtD
Aminophylline—Pruritus—Etoposide—urinary bladder cancer	0.000435	0.00119	CcSEcCtD
Aminophylline—Arrhythmia—Epirubicin—urinary bladder cancer	0.000433	0.00119	CcSEcCtD
Aminophylline—Alopecia—Epirubicin—urinary bladder cancer	0.000428	0.00118	CcSEcCtD
Aminophylline—Nausea—Gemcitabine—urinary bladder cancer	0.000428	0.00117	CcSEcCtD
Aminophylline—Vomiting—Cisplatin—urinary bladder cancer	0.000427	0.00117	CcSEcCtD
Aminophylline—Rash—Cisplatin—urinary bladder cancer	0.000423	0.00116	CcSEcCtD
Aminophylline—Dermatitis—Cisplatin—urinary bladder cancer	0.000423	0.00116	CcSEcCtD
Aminophylline—Diarrhoea—Etoposide—urinary bladder cancer	0.000421	0.00115	CcSEcCtD
Aminophylline—Nausea—Fluorouracil—urinary bladder cancer	0.00042	0.00115	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—urinary bladder cancer	0.000416	0.00114	CcSEcCtD
Aminophylline—Tension—Epirubicin—urinary bladder cancer	0.000414	0.00114	CcSEcCtD
Aminophylline—Nervousness—Epirubicin—urinary bladder cancer	0.00041	0.00113	CcSEcCtD
Aminophylline—Dizziness—Etoposide—urinary bladder cancer	0.000406	0.00112	CcSEcCtD
Aminophylline—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000401	0.0011	CcSEcCtD
Aminophylline—Nausea—Cisplatin—urinary bladder cancer	0.000398	0.00109	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—urinary bladder cancer	0.000396	0.00109	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—urinary bladder cancer	0.000391	0.00107	CcSEcCtD
Aminophylline—Vomiting—Etoposide—urinary bladder cancer	0.000391	0.00107	CcSEcCtD
Aminophylline—Agitation—Epirubicin—urinary bladder cancer	0.000388	0.00106	CcSEcCtD
Aminophylline—Rash—Etoposide—urinary bladder cancer	0.000388	0.00106	CcSEcCtD
Aminophylline—Dermatitis—Etoposide—urinary bladder cancer	0.000387	0.00106	CcSEcCtD
Aminophylline—Headache—Etoposide—urinary bladder cancer	0.000385	0.00106	CcSEcCtD
Aminophylline—Tension—Doxorubicin—urinary bladder cancer	0.000383	0.00105	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—urinary bladder cancer	0.000379	0.00104	CcSEcCtD
Aminophylline—Palpitations—Epirubicin—urinary bladder cancer	0.000373	0.00102	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000368	0.00101	CcSEcCtD
Aminophylline—Convulsion—Epirubicin—urinary bladder cancer	0.000366	0.001	CcSEcCtD
Aminophylline—Infection—Methotrexate—urinary bladder cancer	0.000366	0.001	CcSEcCtD
Aminophylline—Nausea—Etoposide—urinary bladder cancer	0.000365	0.001	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000361	0.000991	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—urinary bladder cancer	0.000359	0.000985	CcSEcCtD
Aminophylline—Anxiety—Epirubicin—urinary bladder cancer	0.000358	0.000983	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—urinary bladder cancer	0.000351	0.000963	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—urinary bladder cancer	0.000345	0.000947	CcSEcCtD
Aminophylline—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000345	0.000946	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—urinary bladder cancer	0.000344	0.000944	CcSEcCtD
Aminophylline—Infection—Epirubicin—urinary bladder cancer	0.000342	0.000939	CcSEcCtD
Aminophylline—Shock—Epirubicin—urinary bladder cancer	0.000339	0.00093	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—urinary bladder cancer	0.000338	0.000929	CcSEcCtD
Aminophylline—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000338	0.000927	CcSEcCtD
Aminophylline—Tachycardia—Epirubicin—urinary bladder cancer	0.000336	0.000923	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—urinary bladder cancer	0.000333	0.000914	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—urinary bladder cancer	0.000331	0.00091	CcSEcCtD
Aminophylline—Anorexia—Epirubicin—urinary bladder cancer	0.000328	0.000901	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—urinary bladder cancer	0.000324	0.00089	CcSEcCtD
Aminophylline—Hypotension—Epirubicin—urinary bladder cancer	0.000322	0.000884	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—urinary bladder cancer	0.00032	0.000878	CcSEcCtD
Aminophylline—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000319	0.000875	CcSEcCtD
Aminophylline—Infection—Doxorubicin—urinary bladder cancer	0.000317	0.000869	CcSEcCtD
Aminophylline—Shock—Doxorubicin—urinary bladder cancer	0.000314	0.000861	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000313	0.000858	CcSEcCtD
Aminophylline—Insomnia—Epirubicin—urinary bladder cancer	0.000312	0.000855	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—urinary bladder cancer	0.000311	0.000854	CcSEcCtD
Aminophylline—Anorexia—Doxorubicin—urinary bladder cancer	0.000304	0.000834	CcSEcCtD
Aminophylline—Dyspepsia—Epirubicin—urinary bladder cancer	0.000303	0.000832	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000301	0.000826	CcSEcCtD
Aminophylline—Decreased appetite—Epirubicin—urinary bladder cancer	0.000299	0.000822	CcSEcCtD
Aminophylline—Hypotension—Doxorubicin—urinary bladder cancer	0.000298	0.000818	CcSEcCtD
Aminophylline—Urticaria—Methotrexate—urinary bladder cancer	0.000292	0.000803	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—urinary bladder cancer	0.000291	0.000799	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—urinary bladder cancer	0.000291	0.000799	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—urinary bladder cancer	0.000288	0.000791	CcSEcCtD
Aminophylline—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000282	0.000773	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000281	0.00077	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000277	0.000761	CcSEcCtD
Aminophylline—Urticaria—Epirubicin—urinary bladder cancer	0.000274	0.000751	CcSEcCtD
Aminophylline—Abdominal pain—Epirubicin—urinary bladder cancer	0.000272	0.000748	CcSEcCtD
Aminophylline—Body temperature increased—Epirubicin—urinary bladder cancer	0.000272	0.000748	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000271	0.000745	CcSEcCtD
Aminophylline—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000261	0.000716	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—urinary bladder cancer	0.00026	0.000715	CcSEcCtD
Aminophylline—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000254	0.000697	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—urinary bladder cancer	0.000253	0.000695	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000252	0.000692	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000252	0.000692	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—urinary bladder cancer	0.000252	0.000691	CcSEcCtD
Aminophylline—Pruritus—Epirubicin—urinary bladder cancer	0.000244	0.000669	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—urinary bladder cancer	0.000243	0.000668	CcSEcCtD
Aminophylline—Diarrhoea—Epirubicin—urinary bladder cancer	0.000236	0.000647	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000235	0.000645	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—urinary bladder cancer	0.000234	0.000643	CcSEcCtD
Aminophylline—Rash—Methotrexate—urinary bladder cancer	0.000232	0.000637	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—urinary bladder cancer	0.000232	0.000637	CcSEcCtD
Aminophylline—Headache—Methotrexate—urinary bladder cancer	0.000231	0.000633	CcSEcCtD
Aminophylline—Dizziness—Epirubicin—urinary bladder cancer	0.000228	0.000625	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—urinary bladder cancer	0.000226	0.000619	CcSEcCtD
Aminophylline—Vomiting—Epirubicin—urinary bladder cancer	0.000219	0.000601	CcSEcCtD
Aminophylline—Nausea—Methotrexate—urinary bladder cancer	0.000219	0.0006	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000218	0.000599	CcSEcCtD
Aminophylline—Rash—Epirubicin—urinary bladder cancer	0.000217	0.000596	CcSEcCtD
Aminophylline—Dermatitis—Epirubicin—urinary bladder cancer	0.000217	0.000596	CcSEcCtD
Aminophylline—Headache—Epirubicin—urinary bladder cancer	0.000216	0.000592	CcSEcCtD
Aminophylline—Dizziness—Doxorubicin—urinary bladder cancer	0.000211	0.000579	CcSEcCtD
Aminophylline—Nausea—Epirubicin—urinary bladder cancer	0.000205	0.000562	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—urinary bladder cancer	0.000203	0.000556	CcSEcCtD
Aminophylline—Rash—Doxorubicin—urinary bladder cancer	0.000201	0.000552	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—urinary bladder cancer	0.000201	0.000551	CcSEcCtD
Aminophylline—Headache—Doxorubicin—urinary bladder cancer	0.0002	0.000548	CcSEcCtD
Aminophylline—Nausea—Doxorubicin—urinary bladder cancer	0.000189	0.00052	CcSEcCtD
Aminophylline—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	8.11e-05	0.000311	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CXCL8—urinary bladder cancer	8.02e-05	0.000308	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—HRAS—urinary bladder cancer	7.98e-05	0.000307	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—IL2—urinary bladder cancer	7.91e-05	0.000304	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CXCL8—urinary bladder cancer	7.8e-05	0.0003	CbGpPWpGaD
Aminophylline—HDAC2—Disease—FGFR3—urinary bladder cancer	7.79e-05	0.000299	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TYMP—urinary bladder cancer	7.75e-05	0.000298	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—FGFR3—urinary bladder cancer	7.72e-05	0.000296	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	7.69e-05	0.000295	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NAT1—urinary bladder cancer	7.69e-05	0.000295	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL2—urinary bladder cancer	7.67e-05	0.000294	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TERT—urinary bladder cancer	7.64e-05	0.000293	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.56e-05	0.00029	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CXCL8—urinary bladder cancer	7.51e-05	0.000289	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—KRAS—urinary bladder cancer	7.51e-05	0.000288	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—ESR1—urinary bladder cancer	7.5e-05	0.000288	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—S100B—urinary bladder cancer	7.5e-05	0.000288	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL2—urinary bladder cancer	7.46e-05	0.000286	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TERT—urinary bladder cancer	7.43e-05	0.000285	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—PPARG—urinary bladder cancer	7.43e-05	0.000285	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—RHOA—urinary bladder cancer	7.28e-05	0.000279	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL2—urinary bladder cancer	7.18e-05	0.000276	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TERT—urinary bladder cancer	7.15e-05	0.000275	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—CREBBP—urinary bladder cancer	7.14e-05	0.000274	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	7.03e-05	0.00027	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—FGFR3—urinary bladder cancer	7.01e-05	0.000269	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NAT2—urinary bladder cancer	7.01e-05	0.000269	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—S100B—urinary bladder cancer	6.97e-05	0.000268	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—FGFR3—urinary bladder cancer	6.82e-05	0.000262	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—ESR1—urinary bladder cancer	6.81e-05	0.000261	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NCOR1—urinary bladder cancer	6.74e-05	0.000259	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—urinary bladder cancer	6.67e-05	0.000256	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CREBBP—urinary bladder cancer	6.63e-05	0.000255	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—ESR1—urinary bladder cancer	6.62e-05	0.000254	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—RHOA—urinary bladder cancer	6.61e-05	0.000254	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CREBBP—urinary bladder cancer	6.57e-05	0.000252	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—FGFR3—urinary bladder cancer	6.56e-05	0.000252	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IGF1—urinary bladder cancer	6.49e-05	0.000249	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—EGFR—urinary bladder cancer	6.46e-05	0.000248	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.39e-05	0.000245	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—HRAS—urinary bladder cancer	6.38e-05	0.000245	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—ESR1—urinary bladder cancer	6.38e-05	0.000245	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	6.33e-05	0.000243	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NCOR1—urinary bladder cancer	6.27e-05	0.000241	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.26e-05	0.00024	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—IL2—urinary bladder cancer	6.1e-05	0.000234	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—KRAS—urinary bladder cancer	6.1e-05	0.000234	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—RRM2—urinary bladder cancer	6.05e-05	0.000232	CbGpPWpGaD
Aminophylline—HDAC2—Disease—RHOA—urinary bladder cancer	6e-05	0.00023	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	5.98e-05	0.00023	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CREBBP—urinary bladder cancer	5.97e-05	0.000229	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—RHOA—urinary bladder cancer	5.95e-05	0.000228	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TERT—urinary bladder cancer	5.94e-05	0.000228	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.93e-05	0.000228	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.93e-05	0.000228	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IGF1—urinary bladder cancer	5.89e-05	0.000226	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—EGFR—urinary bladder cancer	5.86e-05	0.000225	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	5.83e-05	0.000224	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CREBBP—urinary bladder cancer	5.8e-05	0.000223	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	5.8e-05	0.000223	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IGF1—urinary bladder cancer	5.73e-05	0.00022	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—EGFR—urinary bladder cancer	5.7e-05	0.000219	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	5.6e-05	0.000215	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ENO2—urinary bladder cancer	5.6e-05	0.000215	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CREBBP—urinary bladder cancer	5.59e-05	0.000215	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ERBB2—urinary bladder cancer	5.55e-05	0.000213	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL2—urinary bladder cancer	5.54e-05	0.000213	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—KRAS—urinary bladder cancer	5.54e-05	0.000213	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TERT—urinary bladder cancer	5.52e-05	0.000212	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IGF1—urinary bladder cancer	5.52e-05	0.000212	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—ERBB2—urinary bladder cancer	5.5e-05	0.000211	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—EGFR—urinary bladder cancer	5.49e-05	0.000211	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FGFR3—urinary bladder cancer	5.45e-05	0.000209	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	5.43e-05	0.000209	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—urinary bladder cancer	5.43e-05	0.000208	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.43e-05	0.000208	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—RHOA—urinary bladder cancer	5.4e-05	0.000207	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—KRAS—urinary bladder cancer	5.39e-05	0.000207	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ESR1—urinary bladder cancer	5.3e-05	0.000203	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—RHOA—urinary bladder cancer	5.25e-05	0.000202	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CXCL8—urinary bladder cancer	5.22e-05	0.0002	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—KRAS—urinary bladder cancer	5.19e-05	0.000199	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—HRAS—urinary bladder cancer	5.19e-05	0.000199	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FGFR3—urinary bladder cancer	5.07e-05	0.000195	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—RHOA—urinary bladder cancer	5.06e-05	0.000194	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—ERBB2—urinary bladder cancer	5e-05	0.000192	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL2—urinary bladder cancer	4.99e-05	0.000192	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ESR1—urinary bladder cancer	4.92e-05	0.000189	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.89e-05	0.000188	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCND1—urinary bladder cancer	4.86e-05	0.000187	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—ERBB2—urinary bladder cancer	4.86e-05	0.000187	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CDKN1A—urinary bladder cancer	4.74e-05	0.000182	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CXCL8—urinary bladder cancer	4.74e-05	0.000182	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTEN—urinary bladder cancer	4.73e-05	0.000182	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MMP9—urinary bladder cancer	4.72e-05	0.000181	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—HRAS—urinary bladder cancer	4.71e-05	0.000181	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	4.7e-05	0.000181	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTEN—urinary bladder cancer	4.69e-05	0.00018	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—ERBB2—urinary bladder cancer	4.68e-05	0.00018	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.67e-05	0.000179	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.66e-05	0.000179	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CREBBP—urinary bladder cancer	4.64e-05	0.000178	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.61e-05	0.000177	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CXCL8—urinary bladder cancer	4.61e-05	0.000177	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IGF1—urinary bladder cancer	4.58e-05	0.000176	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—HRAS—urinary bladder cancer	4.58e-05	0.000176	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL2—urinary bladder cancer	4.53e-05	0.000174	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NQO1—urinary bladder cancer	4.51e-05	0.000173	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EP300—urinary bladder cancer	4.51e-05	0.000173	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.5e-05	0.000173	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EP300—urinary bladder cancer	4.48e-05	0.000172	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.47e-05	0.000172	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CXCL8—urinary bladder cancer	4.44e-05	0.00017	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCND1—urinary bladder cancer	4.42e-05	0.00017	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—HRAS—urinary bladder cancer	4.41e-05	0.000169	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL2—urinary bladder cancer	4.41e-05	0.000169	CbGpPWpGaD
Aminophylline—HDAC2—Disease—SRC—urinary bladder cancer	4.39e-05	0.000169	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SRC—urinary bladder cancer	4.35e-05	0.000167	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CREBBP—urinary bladder cancer	4.31e-05	0.000166	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCND1—urinary bladder cancer	4.3e-05	0.000165	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MMP9—urinary bladder cancer	4.29e-05	0.000165	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.27e-05	0.000164	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTEN—urinary bladder cancer	4.26e-05	0.000164	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IGF1—urinary bladder cancer	4.26e-05	0.000164	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL2—urinary bladder cancer	4.24e-05	0.000163	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—EGFR—urinary bladder cancer	4.24e-05	0.000163	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MYC—urinary bladder cancer	4.24e-05	0.000163	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.21e-05	0.000162	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RHOA—urinary bladder cancer	4.2e-05	0.000161	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MMP9—urinary bladder cancer	4.17e-05	0.00016	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.16e-05	0.00016	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTEN—urinary bladder cancer	4.15e-05	0.000159	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—urinary bladder cancer	4.13e-05	0.000159	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EP300—urinary bladder cancer	4.06e-05	0.000156	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MMP9—urinary bladder cancer	4.01e-05	0.000154	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—urinary bladder cancer	4e-05	0.000154	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CDKN1A—urinary bladder cancer	4e-05	0.000154	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTEN—urinary bladder cancer	3.99e-05	0.000153	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EP300—urinary bladder cancer	3.95e-05	0.000152	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SRC—urinary bladder cancer	3.95e-05	0.000152	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—urinary bladder cancer	3.93e-05	0.000151	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RHOA—urinary bladder cancer	3.9e-05	0.00015	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—urinary bladder cancer	3.9e-05	0.00015	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ERBB2—urinary bladder cancer	3.89e-05	0.000149	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—urinary bladder cancer	3.85e-05	0.000148	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SRC—urinary bladder cancer	3.84e-05	0.000148	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—urinary bladder cancer	3.81e-05	0.000147	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EP300—urinary bladder cancer	3.81e-05	0.000146	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.77e-05	0.000145	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SRC—urinary bladder cancer	3.7e-05	0.000142	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCL8—urinary bladder cancer	3.69e-05	0.000142	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.64e-05	0.00014	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—urinary bladder cancer	3.63e-05	0.00014	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ERBB2—urinary bladder cancer	3.61e-05	0.000139	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—urinary bladder cancer	3.6e-05	0.000138	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.59e-05	0.000138	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—urinary bladder cancer	3.54e-05	0.000136	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL2—urinary bladder cancer	3.52e-05	0.000135	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.5e-05	0.000134	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—urinary bladder cancer	3.46e-05	0.000133	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.46e-05	0.000133	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.46e-05	0.000133	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—urinary bladder cancer	3.45e-05	0.000132	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—urinary bladder cancer	3.43e-05	0.000132	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL8—urinary bladder cancer	3.43e-05	0.000132	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HRAS—urinary bladder cancer	3.4e-05	0.000131	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—urinary bladder cancer	3.37e-05	0.000129	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.37e-05	0.000129	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.37e-05	0.000129	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.35e-05	0.000129	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MMP9—urinary bladder cancer	3.33e-05	0.000128	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1A—urinary bladder cancer	3.32e-05	0.000128	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—urinary bladder cancer	3.32e-05	0.000127	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTEN—urinary bladder cancer	3.31e-05	0.000127	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.31e-05	0.000127	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL2—urinary bladder cancer	3.27e-05	0.000126	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—urinary bladder cancer	3.27e-05	0.000126	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.27e-05	0.000125	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.25e-05	0.000125	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.25e-05	0.000125	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—urinary bladder cancer	3.24e-05	0.000125	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.22e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—urinary bladder cancer	3.2e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—urinary bladder cancer	3.19e-05	0.000123	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—urinary bladder cancer	3.18e-05	0.000122	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EP300—urinary bladder cancer	3.16e-05	0.000121	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MMP9—urinary bladder cancer	3.1e-05	0.000119	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HRAS—urinary bladder cancer	3.09e-05	0.000119	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	3.09e-05	0.000119	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTEN—urinary bladder cancer	3.08e-05	0.000118	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SRC—urinary bladder cancer	3.07e-05	0.000118	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—urinary bladder cancer	3.06e-05	0.000118	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HRAS—urinary bladder cancer	3.06e-05	0.000118	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.06e-05	0.000117	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EP300—urinary bladder cancer	2.94e-05	0.000113	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—urinary bladder cancer	2.91e-05	0.000112	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SRC—urinary bladder cancer	2.86e-05	0.00011	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—urinary bladder cancer	2.83e-05	0.000109	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.81e-05	0.000108	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HRAS—urinary bladder cancer	2.78e-05	0.000107	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—urinary bladder cancer	2.75e-05	0.000106	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—urinary bladder cancer	2.72e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.71e-05	0.000104	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HRAS—urinary bladder cancer	2.71e-05	0.000104	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—urinary bladder cancer	2.69e-05	0.000103	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.63e-05	0.000101	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HRAS—urinary bladder cancer	2.6e-05	0.0001	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.6e-05	9.98e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.6e-05	9.98e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—urinary bladder cancer	2.56e-05	9.83e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—urinary bladder cancer	2.54e-05	9.77e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.52e-05	9.68e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—urinary bladder cancer	2.5e-05	9.62e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.48e-05	9.52e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.38e-05	9.15e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—urinary bladder cancer	2.37e-05	9.09e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.3e-05	8.82e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.26e-05	8.69e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—urinary bladder cancer	2.26e-05	8.69e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.19e-05	8.41e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HRAS—urinary bladder cancer	2.16e-05	8.31e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.1e-05	8.08e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—urinary bladder cancer	2.1e-05	8.08e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.09e-05	8.04e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.08e-05	7.99e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.08e-05	7.99e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HRAS—urinary bladder cancer	2.01e-05	7.72e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.99e-05	7.65e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.96e-05	7.51e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.95e-05	7.49e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.84e-05	7.06e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.75e-05	6.71e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.7e-05	6.53e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.62e-05	6.24e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.62e-05	6.23e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.61e-05	6.17e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.61e-05	6.17e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.54e-05	5.9e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.51e-05	5.8e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.49e-05	5.72e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.43e-05	5.5e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.42e-05	5.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.17e-05	4.5e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.15e-05	4.42e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	4.24e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.02e-05	3.93e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—EP300—urinary bladder cancer	9.75e-06	3.75e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.05e-06	3.48e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.89e-06	3.03e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.53e-06	2.89e-05	CbGpPWpGaD
